Clinical trial
Neutrophils to Lymphocytes and Platelets Ratio (N/LP) as Predictor of Mortality in Septic- Acute Kidney Injury Patients
NCT05559086 is registered in ClinicalTrials.gov with Mahmoud Kamel Mohamed Abd elhaq as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neutrophils to Lymphocytes and Platelets Ratio (N/LP) as Predictor of Mortality in Septic- Acute Kidney Injury Patients
- Lead sponsor
- Mahmoud Kamel Mohamed Abd elhaq
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 25, 2022
- Completion date
- March 25, 2025
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury due to sepsis